Source link : https://newshealth.biz/health-news/another-il-17a-f-blocker-moves-forward-for-psoriatic-arthritis/
(MedPage Today) — A novel drug with the same mechanism as bimekizumab (Bimzelx), but in a smaller molecular package, met its main goals in a phase II study for psoriatic arthritis (PsA), paving the way for registration trials. Called sonelokimab… Source link : https://www.medpagetoday.com/rheumatology/arthritis/117855 Author : Publish date : 2025-10-08 20:42:00 Copyright for syndicated content […]
The post Another IL-17A/F Blocker Moves Forward for Psoriatic Arthritis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-08 20:42:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8